Biopharma | December 09, 2025
Thermo Fisher opens Bioprocess Design Center in Hyderabad
Expands bioprocessing footprint across Asia
Expands bioprocessing footprint across Asia
Biocon will acquire all of Viatris’ convertible preferred equity in Biocon Biologics for $400 million in cash and $415 million in newly issued Biocon shares
The study met its primary endpoint and all 11 secondary efficacy endpoints
_Logo_256_384.png){kind=logo}
The Vital Shape panels provide tiered assessments to detect obesity-related risks early
The EMBOLD study evaluated relutrigine for patients with SCN2A and SCN8A developmental and epileptic encephalopathies
Alport Syndrome is caused by genetic mutations affecting type IV collagen in the kidneys, ears, and eyes
MRI is particularly valuable in pediatric care due to its non-invasive nature
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
Valorum will advance the commercialization and distribution of Armlupeg in the United States
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Subscribe To Our Newsletter & Stay Updated
